SCHEMBL4693729

SCHEMBL4693729

COC(=O)N(CC(=O)O)C(C(=O)O)c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX5 P09917 1/20 0.38
CYP2C19 P33261 3/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
GPX4 P36969 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5185241 0.91 NPSR1 (0.39) LMNANPSR1TP53POLBTHRB
SCHEMBL4693070 0.85 GSTO1 (0.36) LMNANPSR1TP53POLBTHRB
SCHEMBL5252111 0.80 KMT2A (0.43) ALDH1A1KMT2ACYP2D6TSHRSMN1; SMN2
SCHEMBL4138910 0.75 GSTO1 (0.36) LMNANPSR1TP53POLBTHRB
SCHEMBL755753 0.73 ALOX5 (0.47) LMNANPSR1TP53POLBTHRB
SCHEMBL24328836 0.68 ALOX5 (0.45) LMNANPSR1TP53POLBTHRB
SCHEMBL11407054 0.68 ALOX5 (0.45) LMNANPSR1TP53POLBTHRB
SCHEMBL12532108 0.68 ALOX5 (0.45) LMNANPSR1TP53POLBTHRB
SCHEMBL7339170 0.68 LMNA (0.47) LMNANPSR1TP53POLBTHRB
SCHEMBL11780036 0.68 TSHR (0.41) LMNANPSR1TP53POLBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed
EP-1798231-A2 Intermediate products for the preparation of antibacterial compounds NOVEXEL (FR) 2007-06-20 EP disclosed
EP-1399444-B1 NOVEL HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS NOVEXEL (FR) 2007-04-11 EP disclosed